Foley & Lardner LLP represented Essenvia, a regulatory submission platform for MedTech organizations, in its Series A financing.
Essenvia helps MedTech organizations rapidly submit eSTAR, EUMDR, and IVDR, eliminate common submission errors, and maximize their device’s revenue potential. Unlike conventional Regulatory Information Management (RIM) tools, documents, or spreadsheets, Essenvia has zero technical implementation time and works seamlessly with a regulatory team’s existing process. The platform empowers teams to natively collaborate on 510(k), MDR, and IVDR submissions directly inside of a submission, error check them, dynamically publish and republish them with one click, and instantly submit using the latest agency-specific technical requirements. Essenvia has a 100% acceptance rate across hundreds of different types of complex global submissions.
The funds from the investment round will support company operations, team expansion, product innovation, sales, and distribution.
The Foley team was led by of counsel Alidad Vakili and associates Ashley Lee and Trevor Mullin.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.